MRI revealed a new right temporal lobe brain lesion in a 68‐year‐old female with refractory DLBCL following CAR‐T therapy.[183] Subsequent analysis identified anti‐CD19 CAR‐T cells in the cerebrospinal fluid. Here, CD19 is linked to diffuse large B-cell lymphoma.